Medications
Compounded semaglutide & tirzepatide (injection + sublingual oral)
Monthly Cost
$130 – $300
Speed to Start
Same-day async approval
Compounded Medications
Longevity Multi-Modality
About Oak Weight Loss Program
Oak Weight Loss Program is the GLP-1 product line of Oak Longevity Holdings Corp., a Delaware-registered telehealth company that markets a full longevity stack — compounded semaglutide and tirzepatide for weight loss, plus NAD+, Tadalafil, Sermorelin, and other peptide protocols under the same brand. The company operates at oaklovesyou.com and advertises pricing as low as $130/month for compounded semaglutide and $199/month for compounded tirzepatide, with a “one price, all dosages, no subscriptions” pitch and free shipping on every plan.
The actual prices a patient sees inside the funnel are higher than the homepage marketing — $235/month for a one-month semaglutide plan and $285/month for a one-month tirzepatide plan, with the lower advertised tier reserved for longer multi-month commitments. The promo code OAKNEW50 takes $50 off the first month, and the company offers a money-back guarantee that triggers only if a physician declines to approve the prescription. Once medication ships, refunds are not issued under any circumstances — a standard compounded-pharmacy policy, but worth knowing before you commit to a multi-month plan.
What makes Oak’s intake unusually rigorous for a fast async provider is the clinical screening depth. Oak’s questionnaire captures personal AND family history for medullary thyroid cancer and MEN-2 syndrome (the FDA black-box contraindications) — most compounded providers in our catalog only ask about personal history. The flow also requires a full-body clothed photo upload for the physician’s review (a form of identity-and-body-composition verification we have not seen at any other compounded provider), captures eating disorders explicitly, and runs a separate GLP-1-drug-specific allergy multi-select against Ozempic, Mounjaro, Wegovy, Zepbound, Saxenda, and Trulicity. Free-text medication and allergy fields supplement the structured checkboxes. What it doesn’t include: a validated PHQ depression screen, any substance-use questions, or detailed exercise history.
Where Oak loses ground is on operational transparency. The company does not publicly name a founder, CEO, or founding date — there is no executive LinkedIn, no Crunchbase entry, and no press releases of substance. The Better Business Bureau profile we located is registered to a Vancouver, BC, Canada address despite the corporation’s Delaware filing. Oak claims its compounded medications come from state-licensed 503B pharmacies, but no specific pharmacy partners are named publicly — a gap that competitors like OrderlyMeds and Mochi have closed by listing their compounders directly. Trustpilot sits at roughly 4.0 stars, but the volume of only 46 reviews means external sentiment is too thin to draw firm conclusions in either direction.
For the right patient — someone who values same-day async approval, the sublingual oral semaglutide option for needle-aversion, the broader Oak Longevity catalog (peptides, NAD+, Tadalafil), and the lowest advertised price points in the compounded category — Oak is a serious option. For patients who weight verifiable ownership, named pharmacy partners, and refund flexibility above all else, the trade-offs are real and worth the additional due diligence before locking in.
At a Glance
Medications Offered
Compounded semaglutide, Compounded tirzepatide
Compounded — Subcutaneous + Sublingual Oral
Cost & Insurance
- Monthly: $130 – $300
- 6-month estimate: $780 – $1,800
- Insurance: No
- Self-pay: Yes (HSA / FSA not advertised)
Clinical Features
- Lab testing: Optional add-on (separate labtests.oaklovesyou.com)
- Dietitian access: Free health coaching included (group; RD credentials not disclosed)
- Verified Pharmacy: Not publicly disclosed (claims state-licensed 503B)
- BBB Rating: Not Accredited
Delivery & Access
- Format: Subcutaneous, Sublingual oral
- Nationwide telehealth: 45 states
- Speed: Same-day async approval
- Spanish-speaking providers: Not advertised
Oak GLP-1 Medications
Start your GLP-1 weight loss journey with Oak today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
What the Oak Intake Looks Like
We walked through Oak’s full GLP-1 intake ourselves, from the front-loaded medication picker through the email-and-password account creation, the long-scrolling clinical questionnaire with personal-and-family-history MTC/MEN-2 screens, the required full-body photo upload, and the four-step consent stack. Here’s what an actual prospective patient encounters before being prescribed.
/ 10
Above average for the compounded category. Captures personal AND family history for medullary thyroid cancer and MEN-2 (only a handful of providers in our catalog do both), separates pancreatitis, gastroparesis, and triglycerides >600 mg/dL as discrete checkboxes, includes a dedicated eating-disorder item, runs a GLP-1-drug-specific allergy multi-select against six branded molecules, and requires a full-body clothed photo upload for the prescribing physician. Knocked down by no validated PHQ depression instrument, no substance-use or alcohol panel, and only a single-question diet/exercise depth.
/ 10
Moderate. Account creation (email + password) is required upfront after medication selection but before clinical screening, the full-body photo step is unusual and slows the flow, and the four-step consent stack at the end (off-label, individualized treatment, truthfulness, GLP-1 indication) adds checkbox count. Mitigated by no required video call, same-day approval, and Klarna-style multi-step billing not enforced.
The 5 Stages
Clinical Safety Screens Performed
No validated PHQ-2 or PHQ-9 depression screen and no self-harm question. No mental-health screen of any kind beyond eating disorders. No substance-use or alcohol panel. No structured family-history capture beyond MTC/MEN-2. No detailed exercise history — diet and exercise are collapsed into a single “approach to weight management” question with three-option granularity (Active managing / Some efforts / No active efforts). Sex is captured as Male / Female only. Phone OTP is not visible in the flow despite phone being collected. The four-step consent stack at the end is positive for documentation but means a patient must affirmatively click through four separate legal acknowledgments.
Unique to Oak among compounded providers in our catalog: the questionnaire requires a full-body clothed photo of the patient, with a face visible, “to ensure the highest quality of care during your telemedicine consultation” and “to facilitate verification of your identity.” The instructions ask for clothed-but-not-baggy apparel and explicitly state the image will be used by the physician for assessment, will remain private, and will not be shared. The patient can take the photo with the device camera or upload a saved file. This step is gating — the questionnaire cannot be submitted without it.
Source: GLP-1.Reviews editorial walkthrough on April 30, 2026. We completed every screen of the Oak weight-loss intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens oaklovesyou.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
